SBC Medical introduces its next-generation wellness initiative focused on innovation, personalized care, and enhanced patient outcomes.
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a management services organization collaborating with numerous franchised businesses across various medical fields, today introduced “SBC Wellness 2.0,” a new wellness and longevity platform that combines aesthetic healthcare, preventative care, and data-driven health management.
This initiative positions SBC Medical in the rapidly expanding longevity market, projected to reach approximately $800 billion by 2025* and nearly $2 trillion by 2035, with a compound annual growth rate exceeding 10% between 2026 and 2035. This strategy builds upon SBC Medical’s core business in the Japanese aesthetic medicine market, estimated at approximately $4 billion. While the Japanese longevity market is already valued at around $34 billion, it is still in its early stages, with no clear market leader yet, presenting the company with a significant opportunity to capitalize on its competitive advantage. SBC Medical intends to leverage its existing network of clinics and customer base in Japan to develop recurring revenue streams and a differentiated, data-rich platform.
“Aesthetic medicine has allowed us to help many people gain confidence in their appearance,” said Yoshiyuki Aikawa, CEO of SBC Medical. “We observed that people seeking a youthful appearance are also very sensitive to the signs of internal physical decline. This observation led to the creation of SBC Wellness 2.0. We are convinced that only SBC Medical can offer a level of care that allows everyone to reach their full potential, both in terms of appearance and physical capabilities. Our ambition is to first revolutionize the Japanese longevity market before expanding internationally.”
*Source: Ocean Report, “Global, US and Japanese Longevity Markets” (published in March 2026)
What is SBC Wellness 2.0?
SBC Wellness 2.0 prioritizes prevention, physical performance, and overall health rather than simply treating illnesses. This service uses blood biomarkers, medical imaging, and artificial intelligence to assess each client’s health status and recommend personalized protocols that may include medical interventions, nutritional supplements, and lifestyle guidance. By integrating “youthful appearance” and “physical optimization,” SBC Medical is creating a new category of “performance medicine” that goes beyond non-medical approaches such as traditional fitness and dietary supplements. The program follows a straightforward path: measurement of key indicators, visualization of biological age and risks, recommendation of a customized plan, ongoing digital coaching, and progress tracking.
Competitive advantages and revenue model
SBC Medical believes it is well-positioned in the longevity market thanks to its network of 283 clinics and approximately 6.5 million annual client visits, making it one of the largest aesthetic medicine data sets in Japan. This large-scale data asset directly contributes to the development of proprietary AI models, creating strong barriers to competition. The company is working on a medical platform covering aesthetic medicine procedures and treatments covered by health insurance, and benefits from extensive experience serving a regular premium clientele. Furthermore, SBC Medical’s expertise in luxury hospitality and user experience (UX) design, developed through managing its luxury clinics, represents a major asset in meeting the needs of this demanding clientele. SBC Medical plans to market Wellness 2.0 through an offering that combines bundled programs for businesses as wellness benefits with premium medical and aesthetic healthcare services, paid for by the patient, sold directly to individuals. This B2B model offers client companies a new form of investment in human capital to optimize recruitment and reduce turnover, while ensuring a high-performing growth model for the company at reduced marketing costs. Management is convinced that this combination of subscription-based corporate contracts and à la carte medical services will generate recurring revenue, improve employee retention, and optimize long-term profitability.
